<![CDATA[
<body> <iframe src="http://www2.blogger.com/navbar.g?targetBlogID=6223270&blogName=biotech+licensing%3A+James+Hatton&publishMode=PUBLISH_MODE_FTP&navbarType=BLUE&layoutType=CLASSIC&homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2Findex.html&searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" height="30px" width="100%" marginwidth="0" marginheight="0" scrolling="no" id="navbar-iframe" frameborder="0"></iframe> <div id="space-for-ie"></div>
]]>
Links for 2006-11-14
- ALSCT CytRx Royalty Agreement of August 28, 2006
ALSCT shall transfer shares of Tribune Co. Common Stock and Berkshire Hathaway Inc. having a value of $24,500,000... CytRx shall pay to ALSCT royalties in the amount of 1.0% of Net Sales of Arimoclomol for ALS - Intuitive Surgical Hansen Medical Cross License Agreement of September 1, 2005
- InNexus EvoGenix Material Transfer Agreement of August 1, 2005
- Volcano Endicott Interconnect Manufacturing Services Agreement of July 18, 2006
- Siga NIH Smallpox Development Agreement of September 29, 2006
- Targacept AstraZeneca Amendment to Collaborative Research and License Agreement of November 10, 2006
- Targacept AstraZeneca Collaborative Research and License Agreement of December 27, 2005
- Boston Scientific Guidant St. Jude Medical Settlement Agreement of July 29, 2006
- Guidelines on the application of Article 81 of the EC Treaty to technology transfer agreements
- Boston Scientific St. Jude Medical CRM Product License Agreement of July 29, 2006
- Boston Scientific St. Jude Medical SCS Product License Agreement of July 29, 2006
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home